Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03475953 |
Title | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE) |
Acronym | REGOMUNE |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Institut Bergonie |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Institut Bergonié | RECRUITING | Bordeaux | 33076 | France | Details | |
Centre Hospitalier Régional Universitaire - CHU Morvan | RECRUITING | Brest | 29200 | France | Details | |
Centre Léon Bérard | RECRUITING | Lyon | 69008 | France | Details | |
Institut de Cancérologie de Montpellier | RECRUITING | Montpellier | 34298 | France | Details | |
Institut Curie | RECRUITING | Paris | 75248 | France | Details | |
IUCT Oncopôle - Institut Claudius Regaud | RECRUITING | Toulouse | 31059 | France | Details | |
Institut Gustave Roussy | RECRUITING | Villejuif | 94800 | France | Details |